Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

04/18/07 Myriad Genetics Presents Azixa's Mode of Action at AACR        

04/18/07 NICE finally approves glioma drugs after finding error in its calculations        

04/18/07 YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan        

04/18/07 Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR Annual Meeting 2007        

04/18/07 A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.        

04/16/07 UCSF brain tumor vaccine trial shows promising results        

04/13/07 Funding fears for new cancer drugs        

04/13/07 Brain cancer drugs approved in England        

04/13/07 Radiotherapy for Glioblastoma in the Elderly.        

04/10/07 Study: Localized radiation may work for some brain cancer patients        

04/09/07 Phase II trial of bevacizumab (Avastin) and irinotecan (CPT-11) in recurrent malignant glioma.        

04/09/07 Phase II trial of bevacizumab (Avastin) and irinotecan (CPT-11) in recurrent malignant glioma.        

03/30/07 Scientists seek £2m cancer laser        

03/29/07 NeoPharm plunges on FDA request        

03/29/07 Protherics starts trial of brain cancer therapy        

03/26/07 Erimos Pharmaceuticals Announces Phase I/Phase II Study of Terameprocol (EM-1421) In Conjunction with New Approaches to Brain Tumor Therapy (NABTT) Consortium        

03/23/07 Stanford brain tumor vaccine to be tested nationally        

03/22/07 Area doctor free of brain tumor for 22 months        

03/22/07 Decision Memo for Blood Brain Barrier Disruption (BBBD) Chemotherapy (CAG-00333N)        

---

Displaying Stories 4070 to 4089 of 7807
Previous 20           Next 20